The transactions highlighted below are representative of Greenhill engagements. In addition, the Firm has completed many engagements that were not publicly-disclosed.
Recent Transactions
Sort By
19-Nov-14
$NA
Target:
Muelles y Ballestas Hispano-Alemanas, S.A.
Acquiror:
Invest Ziur, S.L
Advised The Boler Company, US based parent of truck component supplier Hendrickson, on the sale of its 50% equity stake in Muelles y Ballestas Hispano-Alemanas, S.A., a Spanish manufacturer of leaf springs for commercial vehicles, to its co-shareholder Invest Ziur, S.L.
22-Oct-14
$112 million
Target:
Nuplex Industries’ Specialties and Masterbatch businesses
Acquiror:
CHAMP Private Equity
Advised Nuplex Industries, a dual listed (ASX/NZX) global manufacturer, developer and distributor of resins and additives, on the sale of its specialty chemicals and masterbatch businesses to CHAMP Private Equity, a leading Australian private equity firm
30-Sep-14
$NA
Target:
Masco Corporation
Advised Masco Corporation, a leading global provider of home improvement and building products, on the tax-free spin-off of its Installation Services business
09-Sep-14
$NA
Target:
Atwood Mobile Products, LLC
Acquiror:
Dometic Group AB
Advised Dometic Group AB, a portfolio company of EQT, on its acquisition of Atwood Mobile Products, a global manufacturer of appliances and hardware for the RV, On-/Off-Highway and Marine industries
03-Sep-14
$300 million
Target:
Voya Financial, Inc.
Advised the Independent Committee of the Board of Directors of Voya Financial, Inc. in connection with Voya Financial, Inc.’s repurchase of 7.7mm shares (aggregate repurchase of $300mm) from ING Groep N.V.
11-Aug-14
$420 million
Target:
Tri-Ed
Acquiror:
Anixter International Inc.
Advised Anixter International Inc., a leading global distributor of enterprise cabling and security solutions, electrical and electronic wire and cable, and OEM supply fasteners and other small parts, on its acquisition of Tri-Ed from Audax Group
11-Aug-14
$NA
Target:
MannKind Corporation
Acquiror:
Sanofi
Advised MannKind, a biopharmaceutical company focused on the development of therapeutic products for patients with diabetes, on a collaboration with Sanofi, comprising licensing, supply and loan facility agreements with respect to licensing the Company’s lead product AFREZZA. MannKind will receive up to $925 million in upfront and milestone payments plus 35% of future profits.
05-Aug-14
$1.3 billion
Target:
Siemens Health Services
Acquiror:
Cerner Corporation
Advised Cerner Corporation, a leader in healthcare information services, on the acquisition of the assets of Siemens Aktiengesellschaft’s healthcare information technology business unit, Siemens Health Services, for $1.3 billion in cash.
28-Jul-14
$90 million
Target:
Clinuvel Pharmaceuticals Limited
Acquiror:
Retrophin, Inc.
Advised Clinuvel, a biopharmaceutical company focused on developing drugs for the treatment of a range of severe skin disorders, in response to an unsolicited proposal to acquire the business from Retrophin, a pharmaceutical company focused on the development, acquisition and commercialization of drugs for the treatment of serious, catastrophic or rare diseases
24-Jul-14
$3.0 billion
Target:
QR Energy, LP
Acquiror:
BreitBurn Energy Partners LP
Advised QR Energy, LP on the merger with Breitburn Energy Partners LP to create the largest oil-weighted MLP in the upstream oil & gas sector
26-Jun-14
$2.9 billion
Target:
Firth Rixson Limited
Acquiror:
Alcoa Inc.
Advised Alcoa Inc. on the acquisition of Firth Rixson Limited, a leading provider of highly engineered rings, industrial forgings and specialized metal products primarily to the aerospace industry
26-Jun-14
$2.7 billion
Target:
Frank Russell Company
Acquiror:
London Stock Exchange Group plc
Advised LSEG on the proposed acquisition of Frank Russell Company, the number one provider of benchmarks to US-focused equity funds and a leading provider of multi-asset class investment solutions, from Northwestern Mutual Life Insurance Company, including acting as Joint Sponsor to LSEG on its $1.6 billion rights issue
23-Jun-14
$690 million
Target:
Western World Insurance Group, Inc.
Acquiror:
Validus Holdings, Ltd.
Advised Validus Holdings, Ltd., a leading Bermuda-based provider of reinsurance, insurance, and insurance linked securities management, on its acquisition of Western World Insurance Group, Inc., a specialty US commercial insurer
18-Jun-14
$NA
Target:
Frauenthal Automotive Sales GmbH
Acquiror:
The Boler Company
Advised The Boler Company, parent of truck component supplier Hendrickson, on the acquisition of Frauenthal Automative Sales GmbH, a European manufacturer of leaf springs and stabilizers
01-May-14
$NA
Target:
Filter Specialists, Inc.
Acquiror:
Pall Corporation
Advised Filter Specialists, Inc., a global manufacturer of industrial liquid filtration solutions, on its sale to Pall Corporation
11-Apr-14
$414 million
Target:
Investec Bank (Australia) Limited
Acquiror:
Bank of Queensland Limited
Advised Investec Bank (Australia) Limited on the sale of its Professional Finance and Asset Finance and Leasing businesses, its deposit book, and its Australian banking licence to Bank of Queensland Limited (“BOQ”). BOQ is a leading regional Australian bank which provides retail and business banking
10-Apr-14
$NA
Target:
Flint Group
Acquiror:
Consortium of Goldman Sachs MBD and Koch Industries
Advised Flint Group, a portfolio company of CVC Capital Partners and a global leader in the manufacturing of printing inks and consumables on its sale to a consortium consisting of Goldman Sachs Merchant Banking and the private equity arm of Koch Industries
01-Apr-14
$NA
Target:
Dillard's, Inc. (Credit Card Assets)
Acquiror:
Wells Fargo & Company
Advised Dillard’s, Inc. on a strategic alliance relating to its credit card business with Wells Fargo & Company
18-Feb-14
$25.1 billion
Target:
Forest Laboratories Inc.
Acquiror:
Actavis plc
Advised Actavis plc, a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products on its acquisition of Forest Laboratories Inc.
05-Feb-14
$NA
Target:
Unfors Raysafe AB
Acquiror:
Fluke Biomedical Corporation
Advised the Sixth Swedish National Pension Fund on the sale of Unfors Raysafe AB, a provider of easy-to-use products that help to reduce unnecessary radiation exposure, to Fluke Biomedical Corp., a subsidiary of Danaher Corp. that manufactures biomedical test and simulation products
04-Feb-14
$156 million
Target:
Thiele Kaolin Company
Advised Thiele Kaolin Company, a miner and processor of kaolin clay, on a leveraged capitalization and repurchase of a 40% stock interest from Stora Enso Oyj
18-Dec-13
$NA
Target:
Fidelis SeniorCare Inc. (Michigan Heath Plan)
Acquiror:
Centene Corporation
Advised Fidelis SeniorCare Inc., a healthcare provider focused on the care of the elderly, on the sale of a majority of its SecureCare Michigan health plan to Centene Corporation, a managed care provider focused on the Medicaid space
04-Nov-13
$4.9 billion
Target:
Berry Petroleum Co.
Acquiror:
LINN Energy, LLC
Advised the Independent Directors of LINN Energy, LLC, the largest oil & gas upstream MLP, related to the amended terms of the acquisition of Berry Petroleum Company
28-Oct-13
$1.1 billion
Target:
US Forestlands and Partnership Interest in the South Carolina Real Estate Assets of MeadWestvaco
Acquiror:
Plum Creek Timber
Provided fairness opinion to the Board of Directors of MeadWestvaco Corporation on the sale of its US forestlands and a partnership stake in its South Carolina Real Estate assets to Plum Creek Timber
21-Oct-13
$4.8 billion
Target:
Devon Energy Corporation (US Midstream Assets)
Acquiror:
Crosstex Energy, Inc. & Crosstex Energy, L.P.
Advised Crosstex Energy, Inc. & Crosstex Energy, L.P., a leading US based midstream company, on the creation of a new midstream energy partnership with Devon Energy Corporation, a top-five US independent exploration & production company